Dealing with heterogeneity of treatment effects: is the literature up to the challenge?
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Some patients will experience more or less benefit from treatment than the averages reported from clinical trials; such variation in therapeutic outcome is termed heterogeneity of treatment effects (HTE). Identifying HTE is necessary to individualize treatment. The degree to which heterogeneity is sought and analyzed correctly in the general medical literature is unknown. We undertook this literature sample to track the use of HTE analyses over time, examine the appropriateness of the statistical methods used, and explore the predictors of such analyses. METHODS: Articles were selected through a probability sample of randomized controlled trials (RCTs) published in Annals of Internal Medicine, BMJ, JAMA, The Lancet, and NEJM during odd numbered months of 1994, 1999, and 2004. RCTs were independently reviewed and coded by two abstractors, with adjudication by a third. Studies were classified as reporting: (1) HTE analysis, utilizing a formal test for heterogeneity or treatment-by-covariate interaction, (2) subgroup analysis only, involving no formal test for heterogeneity or interaction; or (3) neither. Chi-square tests and multiple logistic regression were used to identify variables associated with HTE reporting. RESULTS: 319 studies were included. Ninety-two (29%) reported HTE analysis; another 88 (28%) reported subgroup analysis only, without examining HTE formally. Major covariates examined included individual risk factors associated with prognosis, responsiveness to treatment, or vulnerability to adverse effects of treatment (56%); gender (30%); age (29%); study site or center (29%); and race/ethnicity (7%). Journal of publication and sample size were significant independent predictors of HTE analysis (p < 0.05 and p < 0.001, respectively). CONCLUSION: HTE is frequently ignored or incorrectly analyzed. An iterative process of exploratory analysis followed by confirmatory HTE analysis will generate the data needed to facilitate an individualized approach to evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mediators and Moderators of Treatment Effects in Randomized Clinical Trials
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.877 · Cited by 2,562
Kraemer, H. C., Stice, E., Kazdin, A., Offord, D., & Kupfer, D. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.848 · Cited by 1,712 · cited 1×
“[25,30,31] have suggested a sequential approach that could shed light on possible HTE.”
BackgroundStatistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., & Drazen, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr077003 · Cited by 1,445 · cited 15×
“While the proposal of Kraemer et al. makes sense, several small reviews, most published well before the revised CONSORT statement, suggest that testing for HTE is reported in only 25% to 50% of RCTs [18,27,32-35].”
BackgroundInfluentialPocock, S. J., Assmann, S. E., Enos, L. E., & Kasten, L. E. (2002) · Statistics in Medicine · doi:10.1002/sim.1296 · Cited by 1,077
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17709-5 · Cited by 942
Ruggenenti, P., Perna, A., Gherardi, G., Garini, G., Zoccali, C., Salvadori, M., Scolari, F., Schena, F. P., & Remuzzi, G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10363-x · Cited by 910
Moderators of Treatment Outcomes: Clinical, Research, and Policy Importance
Kraemer, H. C., Frank, E., & Kupfer, D. J. (2006) · JAMA · doi:10.1001/jama.296.10.1286 · Cited by 310 · cited 4×
“Instead of comparing the p-values across subgroups, the appropriate way to identify significant HTE is to make statistical comparisons for treatment effects across subgroups, using a test for heterogeneity or interaction [7,17,18,25-27].”
BackgroundMethodInfluentialControversies concerning randomization and additivity in clinical trials.
Senn, S. (2004) · Statistics in Medicine · doi:10.1002/sim.2074 · Cited by 132 · cited 2×
“Real effects can be missed because of inadequate statistical power [16,17], and reported effects may be spurious because of the performance of multiple statistical tests (13–16) and/or due to random intra-individual variability [12,13].”
BackgroundSubgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131 · cited 14×
“While the proposal of Kraemer et al. makes sense, several small reviews, most published well before the revised CONSORT statement, suggest that testing for HTE is reported in only 25% to 50% of RCTs [18,27,32-35].”
BackgroundInfluential
Cited by
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
What Is the Evidence for Physical Therapy Poststroke? A Systematic Review and Meta-Analysis
Veerbeek, J. M., van Wegen, E., van Peppen, R., van der Wees, P. J., Hendriks, E., Rietberg, M., & Kwakkel, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087987 · Cited by 1,203
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.10.008 · Cited by 847
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Kent, D. M., Rothwell, P. M., Ioannidis, J. P., Altman, D. G., & Hayward, R. A. (2010) · Trials · doi:10.1186/1745-6215-11-85 · Cited by 504
Prescription Opioids in Adolescence and Future Opioid Misuse
Miech, R., Johnston, L., O’Malley, P. M., Keyes, K. M., & Heard, K. (2015) · Pediatrics · doi:10.1542/peds.2015-1364 · Cited by 466
Metadata
- Authors
- Gabler, N. B., Duan, N., Liao, D., Elmore, J. G., Ganiats, T. G., & Kravitz, R. L.
- Venue
- Trials
- Published
- 2009-06-19
- Volume
- 10
- Issue
- 1
- Pages
- 43-43
- ISSN
- 1745-6215 (ISSN-L)
- OpenAlex
- W2120104507
- Cited by
- 111
- References
- 9
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dealing with heterogeneity of treatment effects: is the literature up to the challenge? https://app.cochat.ai/papers/10.1186/1745-6215-10-43
- The paper
- Gabler, N. B., Duan, N., Liao, D., Elmore, J. G., Ganiats, T. G., & Kravitz, R. L. (2009). Dealing with heterogeneity of treatment effects: is the literature up to the challenge? Trials. https://doi.org/10.1186/1745-6215-10-43
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.